Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial

BACKGROUND: Based on promising results from radiomic approaches to predict O(6)-methylguanine DNA methyltransferase promoter methylation status (MGMT status) and clinical outcome in patients with newly diagnosed glioblastoma, the current study aimed to evaluate radiomics in recurrent glioblastoma pa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Vils, Alex, Bogowicz, Marta, Tanadini-Lang, Stephanie, Vuong, Diem, Saltybaeva, Natalia, Kraft, Johannes, Wirsching, Hans-Georg, Gramatzki, Dorothee, Wick, Wolfgang, Rushing, Elisabeth, Reifenberger, Guido, Guckenberger, Matthias, Weller, Michael, Andratschke, Nicolaus
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8079773/
https://ncbi.nlm.nih.gov/pubmed/33937035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.636672
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky